Compare Fubotv Inc (FUBO) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fubotv Inc vs Nuwellis Inc — how do they compare? Fubotv Inc trades at $9.38 (market cap $1.02B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Fubotv Inc is far larger — about 463.6× Nuwellis Inc's market cap, and Fubotv Inc is more actively traded (978,631 versus 121,544). Which is the better fit depends on your goals — on Pluang, investors hold Fubotv Inc for 35 Days and Nuwellis Inc for 26 Days on average.
| FUBO | NUWE | |
|---|---|---|
Market Cap | $1.02B | $2.20M |
Volume | 978,631 | 121,544 |
Sector | Media | Health |
52-Week High | $48.96 | $146.65 |
52-Week Low | $8.09 | $0.68 |
Typical Hold Time | 35 Days | 26 Days |
Enterprise Value | $1.19B | -$1.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FUBO trades at $9.25, up 4.76% today, showing technical bearish signals with mixed earnings performance. The company reported Q2 2026 EPS of -$0.25, beating expectations, but missed in Q4 2025. Revenue growth has been strong, reaching $1.62B in 2024 with improving profit margins. Recent developments include new sports streaming agreements and Disney partnership integration driving subscriber growth.
FUBO presents a speculative opportunity with deep valuation discounts (P/E 2.43, P/S 0.19) but faces execution risks amid persistent cash burn. Analyst consensus is mixed with 47% buy ratings and $63.38 price target, representing significant upside potential if turnaround succeeds. Key risks include competitive pressure and path to sustained profitability.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fubotv Inc
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.
Read more on FUBO →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
